Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia
European Journal of Haematology, 05/21/2012
Ojeda–Uribe M et al. – The therapy–related acute myeloid leukemia (t–AML) shared some clinical and biological features such as poor–risk cytogenetics and a rapidly progressing, unfavorable outcome. Retrospective RT–PCR WT1 expression from the onset of APL to t–AML diagnosis did not prove to be a good marker for t–AML development.
